Gastroenterology
Volume 138, Issue 1 , Pages 116-122 , January 2010

Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection

Presented in part as an oral communication at the 43rd Annual Meeting of the European Association for the Study of the Liver; April 23–27, 2008; Milan, Italy.

  • Antonio Ascione

      Affiliations

    • Department of Gastroenterology, Liver Unit, Cardarelli Hospital, Napoli, Italy
    • Corresponding Author InformationReprint requests Address requests for reprints to: Antonio Ascione, MD, Department of Medicine, Center for Liver Disease, Fatebenefratelli Hospital, Via Manzoni, 220-80126 Napoli, Italy. fax: (39) 081-7147081
    • ,
  • Massimo De Luca

      Affiliations

    • Department of Gastroenterology, Liver Unit, Cardarelli Hospital, Napoli, Italy
    • ,
  • Maria Teresa Tartaglione

      Affiliations

    • Department of Gastroenterology, Liver Unit, Cardarelli Hospital, Napoli, Italy
    • ,
  • Filippo Lampasi

      Affiliations

    • Department of Gastroenterology, Liver Unit, Cardarelli Hospital, Napoli, Italy
    • ,
  • Giovan Giuseppe Di Costanzo

      Affiliations

    • Department of Gastroenterology, Liver Unit, Cardarelli Hospital, Napoli, Italy
    • ,
  • Alfonso Galeota Lanza

      Affiliations

    • Department of Gastroenterology, Liver Unit, Cardarelli Hospital, Napoli, Italy
    • ,
  • Francesco Paolo Picciotto

      Affiliations

    • Department of Gastroenterology, Liver Unit, Cardarelli Hospital, Napoli, Italy
    • ,
  • Giuseppina Marino–Marsilia

      Affiliations

    • Department of Gastroenterology, Pathology Unit, Cardarelli Hospital, Napoli, Italy
    • ,
  • Luca Fontanella

      Affiliations

    • Department of Medicine, Centre for Liver Disease, Fatebenefratelli Hospital, Napoli, Italy
    • ,
  • Gioacchino Leandro

      Affiliations

    • Gastroenterology Unit, IRCSS de Bellis, Castellana Grotte, Italy

Received 23 March 2009 ,Accepted 15 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of interest The authors disclose the following: Dr Ascione has received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, Gilead, Grifols, Novartis, Schering-Plough, Roche, and Roche Diagnostics. The remaining authors discloses no conflicts.

PII: S0016-5085(09)01811-3

doi: 10.1053/j.gastro.2009.10.005

Gastroenterology
Volume 138, Issue 1 , Pages 116-122 , January 2010

Article Tools